Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
5,404,173
-
Share change
-
-532,120
-
Total reported value
-
$20,322,000
-
Put/Call ratio
-
89%
-
Price per share
-
$3.76
-
Number of holders
-
31
-
Value change
-
-$2,001,163
-
Number of buys
-
12
-
Number of sells
-
14
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q1 2021
As of 31 Mar 2021,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,404,173 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, STONEHILL CAPITAL MANAGEMENT LLC, MORGAN STANLEY, MARSHALL WACE, LLP, Navellier & Associates Inc, MILLENNIUM MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, and Squarepoint Ops LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.